EMIGH JAMES F 4
4 · ACURA PHARMACEUTICALS, INC · Filed Feb 26, 2021
Insider Transaction Report
Form 4
EMIGH JAMES F
VP Marketing & Administration
Transactions
- Exercise/Conversion
Common Stock
2021-02-24$0.15/sh+20,000$3,020→ 481,592 total - Tax Payment
Common Stock
2021-02-24$0.40/sh−7,550$3,020→ 474,042 total - Exercise/Conversion
Stock options
2021-02-24−20,000→ 0 totalExercise: $0.15From: 2019-12-11Exp: 2023-12-11→ Common Stock (20,000 underlying)
Footnotes (5)
- [F1]Represents payment for exercise price.
- [F2]Exercise price is closing price of Issuer's common stock on December 11, 2018.
- [F3]Awarded under the Acura Pharmaceuticals Inc. 2016 Stock Option Plan
- [F4]100% of the shares underlying the options vest and are exercisable after one year on December 11, 2019
- [F5]Not Applicable.